Fundraising Fox

Sofinnova Ventures β€” 2024 Investments

6 investments dated 2024 Β· listed companies and verified rows first Β· show all

BioAge Labsbioagelabs.comin𝕏NASDAQ: BIOAFeb 2024

BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.

BiotechHealthtechLongevityRichmond, US

Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Executive Officer, Director)inEric Morgen(Director)Dov Goldstein(Executive Officer)

BoardPatrick Enright(Director)in

Board seatJames HealyΒ· per SEC Form D

Co-investorsAndreessen HorowitzElad GilFelicis VenturesIA Seed VenturesLongitude CapitalOrbiMed+4 more

Seaport Therapeuticsseaporttx.comin𝕏NASDAQ: SPTXOct 2024

Seaport Therapeutics develops therapeutics and medicines.

BiotechMental HealthBoston, US

Daphne Zohar(Founder, CEO and Board Member)inMichael Chen(Executive Officer)Lana Gladstein(Executive Officer)Antony Loebel(Executive Officer)Eric Green(Executive Officer)

Board seatJames I. HealyΒ· per SEC Form D

Co-investorsARCH Venture PartnersForesite CapitalHAWKTAILPureTech Health

Axonis Therapeuticsaxonis.usinOct 2024βœ“ verified

Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.

BiotechDeep TechBoston, US

Shane Hegarty(Executive Officer)Shane V. Hegarty(Chief Scientific Officer & Co-Founder)Jeffrey Imbaro(Executive Officer)Joanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)Tiasha Shafiq(Chief of Staff)

Co-investorsvenBio PartnersMRL Ventures FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture PartnersIaso Ventures+7 more

Elektrofi, Inc.Aug 2024SEC filingmedium confidence

Boston, US

Board seatNoel JeeΒ· per SEC Form D Β· $112.3M raise Β· filed Oct 2024

Co-investorsSR One Capital Management

Marea Therapeutics, Inc.Jun 2024SEC filingmedium confidence

San Francisco, US

Board seatMaha KatabiΒ· per SEC Form D Β· $160.4M raise Β· filed Jun 2024

Co-investorsvenBio Partners

DealFormadealforma.comin𝕏May 2024

DealForma is a curated biopharma deals database offering licensing deal comps, M&A data, company and drug pipeline profiles, funding rounds, and Tableau-based interactive dashboards with natural-language search.

BiotechData & InfrastructureHealthtech

Co-investorsTinySeedAlgerRA CapitalREDMILERTW Investments L.P.

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.